Best Oral Birth Control for a Healthy Young Woman

Recommended First-Line Approach

The American Academy of Pediatrics recommends starting with a low-dose monophasic combined oral contraceptive (COC) containing 30-35 μg ethinyl estradiol combined with levonorgestrel or norgestimate for a healthy 22-year-old woman with no contraindications 1
The Centers for Disease Control and Prevention (CDC) guidelines suggest that all low-dose COCs (≤35 μg ethinyl estradiol) are Category 1 (no restrictions) for women aged 22 years 2
COCs are among the best-studied medications ever prescribed, with complete reversibility and no negative effect on long-term fertility, and have a typical-use failure rate of approximately 9% with perfect use approaching 0.3% 1, 3, 4

The American College of Obstetricians and Gynecologists (ACOG) recommends same-day "quick start" initiation of COCs without requiring a gynecologic examination 5
Only blood pressure measurement is needed before initiation, and if started >5 days after menses began, use backup contraception (condoms or abstinence) for 7 days 5, 6

The use of COCs can lead to decreased menstrual cramping and blood loss, improvement in acne, and significant protection against endometrial and ovarian cancers with use >3 years 1
Extended or continuous cycles can be considered after initial cycles if desired for conditions like severe dysmenorrhea, anemia, or menstrual-related symptoms, which can optimize ovarian suppression and may increase contraceptive effectiveness 1

The CDC guidelines state that baseline VTE risk increases from 1-5 per 10,000 woman-years to 3-4 per 10,000 woman-years with COC use, which is substantially lower than pregnancy-related VTE risk (10-20 per 10,000 woman-years) 1, 5
Smoking is NOT a contraindication at age 22, but becomes Category 3-4 at age ≥35 years 5, 7

The American Academy of Pediatrics emphasizes the importance of taking pills at the same time daily to maintain effectiveness and minimize breakthrough bleeding, and providing clear instructions for missed pills 1
Weight gain is not consistently associated with COC use in most formulations, and bleeding irregularities do not indicate medical problems and typically improve over time 1, 5

The CDC guidelines state that rifampin or rifabutin, certain anticonvulsants, and St. John's wort can reduce COC effectiveness, while broad-spectrum antibiotics, antifungals, and antiparasitics do NOT reduce COC effectiveness 6

Norgestimate and levonorgestrel are preferred first-generation and second-generation progestins with well-established safety profiles and lower androgenic effects compared to older formulations, as recommended by the American Heart Association, based on evidence from Hypertension 8